IRELAND — Medtronic, a global leader in medical technology, has appointed Ken Washington as its Chief Technology and Innovation Officer, signaling a strategic move to drive innovation and fuel growth in the healthcare technology market.
Dr. Washington, who will serve as a member of the Medtronic Executive Committee, will play a pivotal role in expanding the use of technology platforms across the company’s vast portfolio.
With a focus on robotics, sensors, implantables, and AI, Dr. Washington aims to enhance returns on investment in innovation while fortifying Medtronic’s technological competitive advantage.
His extensive background in technology leadership positions, including Vice President and General Manager of Consumer Robotics at Amazon and Chief Technology Officer at Ford Motor Company, equips him with the necessary expertise to propel Medtronic’s technological advancements.
Medtronic’s ambitious agenda includes the broader integration of its technology platforms, such as robotics, sensors, implantables, and AI, to foster sustainable growth and strengthen its position as a frontrunner in healthcare technology.
Dr. Washington’s appointment signifies a critical milestone in Medtronic’s commitment to driving innovation-driven growth.
Geoff Martha, CEO of Medtronic, expressed confidence in Dr. Washington’s ability to expand the company’s technology platforms across its portfolio.
Martha believes that leveraging robotics, sensors, implantables, and artificial intelligence will yield improved returns on innovation investments and bolster Medtronic’s competitive edge in the market.
Dr. Washington’s remarkable achievements in the technology realm are evident in his previous roles.
Notably, he led the development and execution of technology strategies as the Chief Technology Officer at Ford Motor Company, overseeing advancements in next-generation vehicle architectures, controls, and automated systems.
He holds a Bachelor of Science, a Master of Science, and a doctorate in nuclear engineering from Texas A&M University.
This newly established position capitalizes on Dr. Washington’s broad experience in driving technology development and execution across diverse industries, including robotics, consumer products, automotive, and space.
Medtronic aims to accelerate innovation-driven growth in alignment with its mission to alleviate pain, restore health, and extend life.
Medtronic’s appointment of Dr. Ken Washington as Chief Technology and Innovation Officer marks a significant leap forward in the company’s pursuit of innovation-driven growth.
With his wealth of experience and proven leadership in technology development, Dr. Washington will harness Medtronic’s pioneering spirit, ensuring the company capitalizes on its scientific and technological knowledge to invent, innovate, and disrupt the future of the healthcare technology market.
This announcement follows Medtronic’s recent acquisition of South Korean wearable insulin patch maker, EOFlow, for a total consideration of KRW 971 billion (US$739 million).
Furthermore, the company reported fourth-quarter sales of US$8.5 billion, reflecting a 5.6% increase compared to the same period last year.
For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.
